Skip to main content

Articles Tagged With: Contraception

  • OTC Birth Control Must Be Accessible to Disadvantaged Groups

    In this Q&A, Contraceptive Technology Update asked Sarah E. Baum, MPH, a senior research scientist at Ibis Reproductive Health in Oakland, CA, about her new study on interest among Black, Indigenous, and people of color in an over-the-counter birth control pill.

  • Telemedicine Abortion Services Benefit Rural Women

    Telemedicine for medication abortion could greatly improve accessibility to rural women and expand abortion accessibility to an additional 3.5 million reproductive-aged women, according to recent research.

  • FDA’s Decision to Allow Pharmacy Sales of Mifepristone Faces Challenges

    The decision by the FDA to permit retail pharmacies to dispense medication abortion pills could remove barriers related to time, distance, and costs for patients in states with laws legalizing abortion care. One possible risk is a lawsuit filed by the Alliance for Hippocratic Medicine, an anti-abortion group that claims the FDA did not approve mifepristone with sufficient scientific evidence.

  • Texas Abortion Ban Is a Warning About the Future

    Abortion access was hit hard by the Texas six-week abortion ban bill and by the Supreme Court’s decision to overturn Roe v. Wade in June 2022. But abortion demand remained high, and women increasingly sought telehealth and out-of-state abortion care.

  • Pregnancy in Abortion-Ban States Is Becoming More Dangerous

    Maternal care and delivery services already are lacking for many pregnant people in the United States, especially in states that have enacted the most restrictive abortion bans nationally. The COVID-19 pandemic and subsequent healthcare labor shortages resulted in more hospitals ending maternal care and delivery. The overturn of Roe v. Wade likely will worsen this already worrisome situation as fewer ED physicians will be trained and experienced in performing an abortion procedure — even to save a pregnant patient’s life.

  • Potentially Wide-Ranging Effects of Abortion Bans on Women’s Health and Safety

    In June 2022, the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization overturned the constitutional right to abortion care. Data are not yet available on whether medical schools and residency programs in abortion-ban states will teach students about abortion or provide any opportunities for hands-on experience with abortion care. Or they could be taught abortion procedures without actual human patients. Media reports indicate that medical students are using papayas in place of a cervix to learn the procedure in some cities.

  • Premenstrual Anxiety, Mood Swings Are Common Among Women Worldwide

    New research shows that women worldwide experience unpleasant premenstrual symtoms, including food cravings (85%) and mood swings or anxiety (64%). Other reported symptoms included fatigue, irritability, bloating, and breast tenderness.

  • Telehealth for Contraception Works, Increasing Access for Patients

    Contraceptive care providers and staff wish to sustain telehealth long past the COVID-19 pandemic era in which telehealth was more widely used, according to a recent study of telehealth in Illinois.

  • FDA’s Change to Emergency Contraception Labeling Is Good News for Women

    In a move that expands access to contraception, the FDA announced that it was changing packaging labels for Plan B, the emergency contraceptive pill that is available over the counter. The box no longer will carry the baseless claim that the pill may prevent a fertilized egg from implanting in the womb.

  • Social Media Trends Are Moving Against Contraception Access

    Reproductive health advocates and providers should be aware of a disturbing social media trend that appears to be moving in the same direction as the early anti-Roe efforts in the 1980s. Decades of attacks on abortion changed enough people’s opinions on abortion to lay the groundwork for the Supreme Court’s Dobbs v. Jackson Women’s Health Organization decision.